The article Beckley Psytech Acquires Eleusis Therapeutics was originally published on Microdose. Beckley Psytech Strengthens Pipeline and Development...
Canadian clinical stage drug development company, Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF), has entered an investigator-initiated clinical...
Privately owned Empyrean Neuroscience, Inc. has launched with a $22 million Series A financing and a genetic engineering platform to advance a pipeline...
Privately-owned psychedelic medicine company Beckley Psytech Limited is buying Eleusis Therapeutics Limited in an all-stock transaction. By acquiring Eleusis,...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
Galan more than doubles Hombre West’s resources to 5.8Mt of contained lithium carbonate equivalent Green Technology Metals secures 100% ownership ......
This month, Alberta, Canada joined the likes of Oregon and (maybe) Colorado in defying federal law to bring much-needed psychedelic treatment to their...
Allkem shares fall as investors digest poor quarter at Mt Cattlin Wet weather hammers Yancoal production but record thermal prices ... Read More The post...
The article Microdose Announces Algernon Pharmaceuticals as Wonderland 2022 Headline Sponsor was originally published on Microdose. The leader in the...
The article Small Pharma Expands IP With Another US Patent was originally published on Microdose. With the recent focus (and fuss) around patent protection...